A Portland State University-led research team has developed a novel chemical compound that shows promise for the treatment ...

KAMPALA, Uganda -- The development of the new malaria medicine from the Basel-based pharmaceutical company Novartis for babies weighing 4½ to 11 pounds has given hope to many, with health workers in ...

Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of ...

Patients who are infected with malaria and dengue virus receive treatment in an isolation ward at a hospital in Pakistan. Drugs known as artemisinins have been remarkably effective in helping malaria ...

(Bloomberg) -- Novartis AG won regulatory approval for the first medicine designed for babies with malaria, the latest development in the global fight against the mosquito-borne disease. The Swiss ...

Severe childhood malaria is linked to long-term cognitive impairment, according to a new study from Indiana University School of Medicine researchers and their collaborators at Makerere University in ...

WHO prequalification of Coartem Baby means newborns can be safely treated rather than using medication for older children ...

Suggested Citation: "Part 3: Advancing Toward Better Malaria Control10 Research and Development for New Antimalarial Drugs." Institute of Medicine. 2004. Saving Lives, Buying Time: Economics of ...

Every year, hundreds of migrant workers arrive at makeshift sapphire and ruby mines near Pailin, Cambodia, risking their lives to unearth gems in the landmine-ridden territory. Soon, however, they ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...